News


Calyxt to Host Third Quarter 2022 Financial Results Conference Call and Webcast on Thursday, November 3, 2022, at 4:30 p.m. Eastern Time

Calyxt to Host Third Quarter 2022 Financial Results Conference Call and Webcast on Thursday, November 3, 2022, at 4:30 p.m. Eastern Time

ROSEVILLE, Minn., Oct. 27, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, will host a conference call and webcast on...
Read More
Calyxt Successfully Produces Plant-Based Squalene, an Important Ingredient in Personal Care Products and Critical Vaccine Adjuvants

Calyxt Successfully Produces Plant-Based Squalene, an Important Ingredient in Personal Care Products and Critical Vaccine Adjuvants

ROSEVILLE, Minn., Oct. 25, 2022 /PRNewswire/ -- Calyxt, Inc. (NASDAQ: CLXT), a plant-based synthetic biology company, announced today that using a Calyxt-engineered...
Read More
Calyxt Announces Agreement with Evologic Technologies to Scale Production of its Plant-based Ingredients

Calyxt Announces Agreement with Evologic Technologies to Scale Production of its Plant-based Ingredients

Agreement will power speed-to-scale strategy to meet the growing interest in high-quality sustainable ingredients across the cosmeceutical, nutraceutical and pharmaceutical...
Read More
Calyxt, Inc. Exploring Strategic Alternatives

Calyxt, Inc. Exploring Strategic Alternatives

ROSEVILLE, Minn., Sept. 22, 2022 /PRNewswire/ -- Calyxt, Inc. (NASDAQ: CLXT) ("Calyxt"), a plant-based synthetic biology company, today announced that its Board...
Read More
Calyxt to Present at the H.C. Wainwright 24th Annual Investment Conference

Calyxt to Present at the H.C. Wainwright 24th Annual Investment Conference

ROSEVILLE, Minn., Sept. 7, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced that Michael A. Carr, President and Chief...
Read More
Next »
« Previous